Ligand Pharmaceuticals Inc (LGND)
Depreciation & Amortization
$8.22M
Quarterly · Period ending: · USD

LGND Depreciation & Amortization
Latest reported$8.22Mperiod ending
Latest reported$8.22Mperiod ending
LGND Quarterly Depreciation & Amortization ($400.00K → $8.22M)
Quarterly Depreciation & Amortization
High-resolution chart · PNG
LGND depreciation & amortization history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Depreciation & Amortization (USD) |
|---|---|
| 8,215,000 | |
| 8,216,000 | |
| 9,624,000 | |
| 8,269,000 | |
| 8,522,000 | |
| 8,770,000 | |
| 8,627,000 | |
| 8,994,000 | |
| 8,853,000 | |
| 8,765,000 | |
| 9,430,000 | |
| 8,611,000 | |
| 9,495,000 | |
| 9,567,000 | |
| 10,070,000 | |
| 13,505,000 | |
| 14,651,000 | |
| 15,134,000 | |
| 9,637,000 | |
| 12,613,000 | |
| 12,292,000 | |
| 13,093,000 | |
| 12,816,000 | |
| 4,548,000 | |
| 4,222,000 | |
| 6,380,000 | |
| 22,036,000 | |
| 8,544,000 | |
| 6,873,000 | |
| 5,086,000 | |
| 3,297,000 | |
| 5,408,000 | |
| 3,011,000 | |
| 3,002,000 | |
| 4,133,000 | |
| 2,017,000 | |
| 2,585,000 | |
| 2,979,000 | |
| 2,968,000 | |
| 2,934,000 | |
| 2,813,000 | |
| 2,575,000 | |
| 687,000 | |
| 644,000 | |
| 646,000 | |
| 650,000 | |
| 659,000 | |
| 661,000 | |
| 669,000 | |
| 668,000 | |
| 656,000 | |
| 668,000 | |
| 669,000 | |
| 670,000 | |
| 749,000 | |
| 638,000 | |
| 662,000 | |
| 678,000 | |
| 691,000 | |
| 750,000 | |
| 785,000 | |
| 564,000 | |
| 95,000 | |
| 669,000 | |
| 703,000 | |
| 745,000 | |
| -736,000 | |
| 1,957,000 | |
| 932,000 | |
| 981,000 | |
| 238,000 | |
| 1,248,000 | |
| -241,000 | |
| -193,000 | |
| 364,000 | |
| 399,000 | |
| 938,000 | |
| 914,000 | |
| 2,688,000 | |
| 4,169,000 | |
| 4,633,000 | |
| 4,727,000 | |
| 4,777,000 | |
| 4,747,000 | |
| 4,724,000 | |
| 4,459,000 | |
| 3,945,000 | |
| 3,870,000 | |
| 3,649,000 | |
| 3,811,000 | |
| 3,582,000 | |
| 3,531,000 | |
| 3,540,000 | |
| 3,627,000 | |
| 5,356,000 | |
| 1,773,000 | |
| 1,719,000 | |
| 1,624,000 | |
| 1,331,000 | |
| 1,710,000 |